Insider Trading - Koppel Adam

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
    "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
    - Peter Lynch
    What is insider trading>>
    Time period:
    Insider Trading Transactions for Koppel Adam
    Goto 0, 1, Next

    Common stock purchase or sale:
    Transaction
    Date    		 Reported
    DateTime    		 Company Symbol Insider
    Relationship    		 Shares
    Traded    		 Average
    Price    		 Total
    Amount    		 Shares
    Owned    		 Filing
    2018-01-30
    Purchase    		 2018-02-01
    7:07 pm    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 300,000 $16 $4,800,000 1,989,444
    (Indirect)    		 View
    2018-06-25
    Purchase    		 2018-06-26
    4:50 pm    		 Aptinyx Inc. APTX Koppel Adam
    Director    		 400,000 $16 $6,400,000 2,225,092
    (Indirect)    		 View
    2018-07-24
    Purchase    		 2018-07-26
    4:27 pm    		 Replimune Group Inc. REPL Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 500,000 $15 $7,500,000 2,838,968
    (Indirect)    		 View
    2019-05-29
    Sale    		 2019-05-31
    4:15 pm    		 Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    Director
    10% Owner    		 1,600,000 $12.5 $20,000,000 7,330,237
    (Indirect)    		 View
    2019-09-17
    Purchase    		 2019-09-19
    7:05 pm    		 SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 150,000 $18 $2,700,000 7,281,307
    (Indirect)    		 View
    2019-11-19
    Sale    		 2019-11-21
    4:26 pm    		 Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 1,750,000 $22.03 $38,552,501 5,580,237
    (Indirect)    		 View
    2019-12-04
    Sale    		 2019-12-06
    5:00 pm    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director    		 1,500,000 $24.68 $37,020,000 4,080,237
    (Indirect)    		 View
    2020-01-14
    Purchase    		 2020-01-16
    4:20 pm    		 Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner    		 3,333,333 $3 $9,999,999 5,558,425
    (Indirect)    		 View
    2020-02-04
    Purchase    		 2020-02-06
    4:26 pm    		 Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner    		 294,117 $17 $4,999,989 3,979,292
    (Indirect)    		 View
    2020-07-28
    Purchase    		 2020-07-28
    4:45 pm    		 Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner    		 400,000 $17 $6,800,000 3,241,628
    (Indirect)    		 View
    2020-10-26
    Purchase    		 2020-10-27
    5:07 pm    		 Aptinyx Inc. APTX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 3,333,333 $3 $9,999,999 8,891,758
    (Indirect)    		 View
    2020-10-27
    Purchase    		 2020-10-29
    8:00 pm    		 Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
    Director
    10% Owner    		 10,000,000 $10 $100,000,000 60,300,064
    (Indirect)    		 View
    2020-11-09
    Purchase    		 2020-11-12
    5:54 pm    		 Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
    Director
    10% Owner    		 332,293 $10.3 $3,422,618 60,632,356
    (Indirect)    		 View
    2020-12-10
    Sale    		 2020-12-14
    5:35 pm    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director    		 1,000,000 $23.4 $23,400,000 3,080,237
    (Indirect)    		 View
    2021-03-09
    Sale    		 2021-03-11
    4:30 pm    		 SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 1,450,000 $71.5 $103,675,000 5,831,307
    (Indirect)    		 View
    2021-07-19
    Purchase    		 2021-07-21
    4:40 pm    		 RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 100,000 $20 $2,000,000 8,434,560
    (Indirect)    		 View
    2021-08-10
    Sale    		 2021-08-12
    8:38 pm    		 SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 1,000,000 $70.25 $70,250,000 4,831,307
    (Indirect
    Direct)    		 View

    Stock options: Exercise, Award, Grant, Conversion
    Transaction
    Date    		 Reported
    DateTime    		 Exercisable
    Expiration    		 Company Symnbol Insider
    Relationship    		 Shares
    Traded    		 Conversion
    Price    		 Shares
    Owned    		 Filing
    2018-01-30
    Exercise    		 2018-02-01
    7:07 pm    		 N/A
    N/A    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 1,689,444 $0 1,689,444
    (Indirect)    		 View
    2018-01-30
    Option Award    		 2018-02-01
    7:07 pm    		 N/A
    N/A    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 1,223,240 $0 1,991,097
    (Indirect)    		 View
    2018-01-30
    Exercise    		 2018-02-01
    7:07 pm    		 N/A
    N/A    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 1,991,097 $0 0
    (Indirect)    		 View
    2018-05-16
    Option Award    		 2018-05-17
    5:10 pm    		 N/A
    2028-05-16    		 TREVENA INC TRVN Koppel Adam
    Director    		 30,000 $0 30,000
    (Direct)    		 View
    2018-06-21
    Option Award    		 2018-06-25
    4:19 pm    		 N/A
    2028-06-21    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    10% Owner    		 25,000 $0 25,000
    (Direct)    		 View
    2018-06-25
    Conversion    		 2018-06-26
    4:50 pm    		 N/A
    N/A    		 Aptinyx Inc. APTX Koppel Adam
    Director    		 1,825,092 $0 1,825,092
    (Indirect)    		 View
    2018-06-25
    Conversion    		 2018-06-26
    4:50 pm    		 N/A
    N/A    		 Aptinyx Inc. APTX Koppel Adam
    Director    		 50,347,396 $0 0
    (Indirect)    		 View
    2018-07-24
    Conversion    		 2018-07-26
    4:27 pm    		 N/A
    N/A    		 Replimune Group Inc. REPL Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 2,338,968 $0 2,338,968
    (Indirect)    		 View
    2018-07-24
    Conversion    		 2018-07-26
    4:27 pm    		 N/A
    N/A    		 Replimune Group Inc. REPL Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 235,146 $0 0
    (Indirect)    		 View
    2018-07-25
    Option Award    		 2018-07-27
    4:36 pm    		 N/A
    2028-07-25    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 1,835 $0 1,835
    (Direct)    		 View
    2018-12-13
    Option Award    		 2018-12-17
    4:46 pm    		 N/A
    2028-12-13    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 8,165 $0 8,165
    (Direct)    		 View
    2019-05-15
    Option Award    		 2019-05-17
    5:29 pm    		 N/A
    2029-05-14    		 Aptinyx Inc. APTX Koppel Adam
    Director    		 40,000 $0 40,000
    (Direct)    		 View
    2019-06-13
    Option Award    		 2019-06-17
    4:26 pm    		 N/A
    2029-06-13    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 10,000 $0 10,000
    (Direct)    		 View
    2019-06-20
    Option Award    		 2019-06-21
    8:02 pm    		 N/A
    2029-06-20    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    10% Owner    		 25,000 $0 25,000
    (Direct)    		 View
    2019-07-30
    Option Award    		 2019-07-30
    4:37 pm    		 N/A
    N/A    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 1,881,720 $4.65 3,871,164
    (Indirect)    		 View
    2019-09-17
    Conversion    		 2019-09-19
    7:05 pm    		 N/A
    N/A    		 SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 6,078,103 $0 6,078,103
    (Indirect)    		 View
    2019-09-17
    Conversion    		 2019-09-19
    7:05 pm    		 N/A
    N/A    		 SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 1,053,204 $0 7,131,307
    (Indirect)    		 View
    2019-09-17
    Conversion    		 2019-09-19
    7:05 pm    		 N/A
    N/A    		 SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 6,078,103 $0 0
    (Indirect)    		 View
    2019-09-17
    Conversion    		 2019-09-19
    7:05 pm    		 N/A
    N/A    		 SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 1,053,204 $0 0
    (Indirect)    		 View
    2020-02-04
    Conversion    		 2020-02-06
    4:26 pm    		 N/A
    N/A    		 Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner    		 2,825,602 $0 2,825,602
    (Indirect)    		 View
    2020-02-04
    Conversion    		 2020-02-06
    4:26 pm    		 N/A
    N/A    		 Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner    		 859,573 $0 3,685,175
    (Indirect)    		 View
    2020-02-04
    Conversion    		 2020-02-06
    4:26 pm    		 N/A
    N/A    		 Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner    		 2,825,602 $0 0
    (Indirect)    		 View
    2020-02-04
    Conversion    		 2020-02-06
    4:26 pm    		 N/A
    N/A    		 Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner    		 859,573 $0 0
    (Indirect)    		 View
    2020-03-31
    Option Award    		 2020-04-02
    4:58 pm    		 N/A
    2030-03-30    		 Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner    		 8,296 $1.356 8,296
    (Direct)    		 View
    2020-05-20
    Option Award    		 2020-05-22
    4:15 pm    		 N/A
    2030-05-19    		 Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner    		 40,000 $0 40,000
    (Direct)    		 View
    2020-06-15
    Option Award    		 2020-06-16
    8:09 pm    		 N/A
    N/A    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director    		 3,333 $0 3,333
    (Direct)    		 View
    2020-06-15
    Option Award    		 2020-06-16
    8:09 pm    		 N/A
    2030-06-14    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director    		 15,000 $0 15,000
    (Direct)    		 View
    2020-06-16
    Option Award    		 2020-06-18
    5:00 pm    		 N/A
    2030-06-16    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 30,000 $0 30,000
    (Direct)    		 View
    2020-06-16
    Option Award    		 2020-06-18
    5:00 pm    		 N/A
    2030-06-16    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 10,000 $0 10,000
    (Direct)    		 View
    2020-06-30
    Option Award    		 2020-07-02
    4:06 pm    		 N/A
    2030-06-29    		 Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner    		 4,370 $2.677 4,370
    (Direct)    		 View
    2020-07-28
    Conversion    		 2020-07-28
    4:45 pm    		 N/A
    N/A    		 Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner    		 2,522,385 $0 2,522,385
    (Indirect)    		 View
    2020-07-28
    Conversion    		 2020-07-28
    4:45 pm    		 N/A
    N/A    		 Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner    		 319,243 $0 2,841,628
    (Indirect)    		 View
    2020-07-28
    Conversion    		 2020-07-28
    4:45 pm    		 N/A
    N/A    		 Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner    		 22,222,220 $0 0
    (Indirect)    		 View
    2020-07-28
    Conversion    		 2020-07-28
    4:45 pm    		 N/A
    N/A    		 Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner    		 2,812,543 $0 0
    (Indirect)    		 View
    2020-09-30
    Option Award    		 2020-10-02
    4:15 pm    		 N/A
    2030-09-29    		 Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner    		 5,663 $2.163 5,663
    (Direct)    		 View
    2020-10-26
    Option Award    		 2020-10-26
    4:30 pm    		 N/A
    N/A    		 BCLS Acquisition Corp. BLSA Koppel Adam
    Director
    10% Owner    		 487,500 $10 487,500
    (Indirect)    		 View
    2020-10-27
    Other    		 2020-10-29
    8:00 pm    		 N/A
    N/A    		 Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
    Director
    10% Owner    		 49,961,944 $0 50,300,064
    (Indirect)    		 View
    2020-12-10
    Option Award    		 2020-12-11
    4:30 pm    		 N/A
    N/A    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 3,189,189 $3.7 7,060,353
    (Indirect)    		 View
    2020-12-31
    Option Award    		 2021-01-05
    4:44 pm    		 N/A
    2030-12-30    		 Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner    		 5,508 $2.224 5,508
    (Direct)    		 View
    2021-03-23
    Option Award    		 2021-03-25
    4:30 pm    		 N/A
    N/A    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 869,565 $5.75 7,929,918
    (Indirect)    		 View
    2021-05-27
    Option Award    		 2021-06-01
    4:30 pm    		 N/A
    2031-05-26    		 Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner    		 40,000 $0 40,000
    (Direct)    		 View
    2021-06-03
    Exercise    		 2021-06-07
    6:50 pm    		 N/A
    N/A    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director    		 3,333 $0 3,333
    (Direct)    		 View
    2021-06-03
    Exercise    		 2021-06-07
    6:50 pm    		 N/A
    N/A    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director    		 3,333 $0 0
    (Direct)    		 View
    2021-06-03
    Option Award    		 2021-06-07
    6:50 pm    		 N/A
    N/A    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director    		 3,333 $0 3,333
    (Direct)    		 View
    2021-06-03
    Option Award    		 2021-06-07
    6:50 pm    		 N/A
    2031-06-02    		 Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director    		 15,000 $0 15,000
    (Direct)    		 View
    2021-06-10
    Option Award    		 2021-06-14
    8:25 pm    		 N/A
    2031-06-10    		 Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
    Director
    10% Owner    		 42,950 $0 42,950
    (Direct)    		 View
    2021-06-16
    Option Award    		 2021-06-21
    5:15 pm    		 N/A
    2031-06-16    		 Solid Biosciences Inc. SLDB Koppel Adam
    Director    		 30,000 $0 30,000
    (Direct)    		 View
    2021-07-13
    Option Award    		 2021-07-14
    4:53 pm    		 2022-07-13
    2031-07-12    		 Foghorn Therapeutics Inc. FHTX Koppel Adam
    Director    		 12,530 $0 12,530
    (Direct)    		 View
    2021-07-19
    Conversion    		 2021-07-21
    4:40 pm    		 N/A
    N/A    		 RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 6,999,998 $0 6,999,998
    (Indirect)    		 View
    2021-07-19
    Conversion    		 2021-07-21
    4:40 pm    		 N/A
    N/A    		 RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 1,334,562 $0 8,334,560
    (Indirect)    		 View
    2021-07-19
    Conversion    		 2021-07-21
    4:40 pm    		 N/A
    N/A    		 RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 35,000,000 $0 0
    (Indirect)    		 View
    2021-07-19
    Conversion    		 2021-07-21
    4:40 pm    		 N/A
    N/A    		 RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner    		 6,672,819 $0 0
    (Indirect)    		 View
    Goto 0, 1, Next